{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:38Z","timestamp":1792783178443,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"GWU","award":["George Washington University McCormick Genomic & Proteomic Center 2018"],"award-info":[{"award-number":["George Washington University McCormick Genomic & Proteomic Center 2018"]}]},{"name":"Hoth Biopharmaceutical Inc, Nevada, USA.","award":["Contract"],"award-info":[{"award-number":["Contract"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11010-019-03677-7","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:02:48Z","timestamp":1576659768000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib"],"prefix":"10.1007","volume":"465","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-8797","authenticated-orcid":false,"given":"Joanna J.","family":"Chmielinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Tong","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Spurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Weglicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"key":"3677_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/17476348.2.2.167","volume":"2","author":"C Schettino","year":"2008","unstructured":"Schettino C, Bareschino MA, Ricci V, Ciardiello F (2008) Erlotinib: an EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment. Expert Rev Respir Med 2:167\u2013178","journal-title":"Expert Rev Respir Med"},{"key":"3677_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(07)70108-0","volume":"8","author":"S Tejpar","year":"2007","unstructured":"Tejpar S, Piessevaux H, Claes K, Piront P, Hoenderop JGJ, Verslype C, Van Cutsem E (2007) Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study. Lancet Oncol 8:387\u2013394","journal-title":"Lancet Oncol"},{"issue":"S1","key":"3677_CR3","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1517\/14740338.2011.606213","volume":"11","author":"F Petrelli","year":"2012","unstructured":"Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Barni S (2012) Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies. Expert Opin Drug Saf 11(S1):S9\u2013S19","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"3677_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/FJC.0000000000000163","volume":"65","author":"IT Mak","year":"2015","unstructured":"Mak IT, Kramer JH, Chmielinska JJ, Spurney CF, Weglicki WB (2015) EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade. J Cardiovasc Pharmacol 65(1):54\u201361","journal-title":"J Cardiovasc Pharmacol"},{"key":"3677_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/386721a0","volume":"386","author":"H Liu","year":"1997","unstructured":"Liu H, Mantyh PW, Basbaum AI (1997) NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386:721\u2013724","journal-title":"Nature"},{"key":"3677_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1749-6632.1993.tb38049.x","volume":"707","author":"M Mishina","year":"1993","unstructured":"Mishina M, Mori H, Araki K, Kushiya E, Meguro H, Kutsuwada T, Kashiwabuchi N, Ikeda K, Nagasawa M, Yamazaki M, Masaki H, Yamakura T, Morita T, Sakimura K (1993) Molecular and functional diversity of the NMDA receptor channel. Ann N Y Acad Sci 707:136\u2013152","journal-title":"Ann N Y Acad Sci"},{"key":"3677_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1749-6632.1993.tb38050.x","volume":"707","author":"M Masu","year":"1993","unstructured":"Masu M, Nakajima Y, Moriyoshi K, Ishii T, Akazawa C, Nakanashi S (1993) Molecular characterization of NMDA and metabotropic glutamate receptors. Ann N Y Acad Sci 707:153\u2013164","journal-title":"Ann N Y Acad Sci"},{"key":"3677_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejca.2017.07.024","volume":"84","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Ghidini M, Lonati V, Tomasello G, Borgonovo K, Ghilardi M, Cabiddu M, Barni S (2017) Efficacy of lapatinib and capcitabine in HER-2 positive breast cancer with brain metastases: a systemic review and pooled analyses. Eur J Cancer 84:141\u2013148","journal-title":"Eur J Cancer"},{"key":"3677_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1742-7843.2010.00556.x","volume":"107","author":"HL Lee","year":"2010","unstructured":"Lee HL, Kim EJ et al (2010) Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization. Basic Clin Pharmacol Toxicol 107:614\u2013618","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3677_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaad.2013.02.025","volume":"69","author":"Y Kiyohara","year":"2013","unstructured":"Kiyohara Y, Yamazaki MD et al (2013) Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. J Am Acad Dermatol 69:463\u2013472","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"3677_CR11","first-page":"531","volume":"19","author":"M Jacouture","year":"2018","unstructured":"Jacouture M, Sibaud V (2018) Toxic side effects of targeted therapies and immunotherapies affecting skin, oral mucosa, hair and nails. Am J Clin Dermatol 19(Suppl 1):531\u2013539","journal-title":"Am J Clin Dermatol"},{"key":"3677_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1139\/y2012-023","volume":"90","author":"WB Weglicki","year":"2012","unstructured":"Weglicki WB, Kramer JH, Spurney CF, Chmielinska JJ, Mak IT (2012) The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction. Can J Physiol Pharmacol 90:1145\u20131149","journal-title":"Can J Physiol Pharmacol"},{"key":"3677_CR13","doi-asserted-by":"publisher","first-page":"R1102","DOI":"10.1152\/ajpregu.00268.2013","volume":"305","author":"IT Mak","year":"2013","unstructured":"Mak IT, Kramer JH, Chen X, Chmielinska JJ, Spurney CF, Weglicki WB (2013) Mg-supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress and cardiac dysfunction in rats. Am J Physiol Regul Integr Comp Physiol 305:R1102\u2013R1111","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"3677_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1139\/y2012-091","volume":"90","author":"JH Kramer","year":"2012","unstructured":"Kramer JH, Spurney CF, Iantorno M, Tziros C, Chmielinska JJ, Mak I-T, Weglicki WB (2012) D-propranolol protects against oxidative stress and progressive cardiac dysfunction in Fe-overloaded rats. Can J Physiol Pharmacol 90(9):1257\u20131268","journal-title":"Can J Physiol Pharmacol"},{"key":"3677_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MAJ.0b013e3181aaee4d","volume":"338","author":"JH Kramer","year":"2009","unstructured":"Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, Chmielinska JJ, Komarov AM, Weglicki WB (2009) Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 338:22\u201327","journal-title":"Am J Med Sci"},{"key":"3677_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12012-009-9040-8","volume":"9","author":"IT Mak","year":"2009","unstructured":"Mak IT, Chmielinska JJ, Kramer JH, Weglicki WB (2009) AZT-Induced cardiovascular toxicity\u2014attenuation by Mg-supplementation. Cardiovasc Toxicol 9:78\u201385","journal-title":"Cardiovasc Toxicol"},{"issue":"3","key":"3677_CR17","doi-asserted-by":"crossref","first-page":"167S","DOI":"10.1684\/mrh.2009.0181","volume":"22","author":"WB Weglicki","year":"2009","unstructured":"Weglicki WB, Chmielinska JJ, Tejero-Taldo MI, Kramer JH, Spurney C, Viswalingham K, Lu B, Mak IT (2009) Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 22(3):167S\u2013173S","journal-title":"Magnes Res"},{"key":"3677_CR18","first-page":"S199","volume":"23","author":"WB Weglicki","year":"2012","unstructured":"Weglicki WB, Mak IT, Chmielinska JJ, Tejero-Taldo MI, Komarov A, Kramer JH (2012) The role of magnesium deficiency in cardiovascular and intestinal inflammation. Magnes Res 23:S199\u2013206","journal-title":"Magnes Res"},{"issue":"8","key":"3677_CR19","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/ijms19082409","volume":"19","author":"IT Mak","year":"2018","unstructured":"Mak IT, Chmielinska JJ, Spurney CF, Weglicki WB, Kramer JH (2018) Combination ART-induced oxidative\/nitrosative stress, neurogenic inflammation and cardiac dysfunction in HIV-1 transgenic (Tg) rats: protection by Mg-supplementation. Int J Mol Sci 19(8):2409\u20132426","journal-title":"Int J Mol Sci"},{"key":"3677_CR20","first-page":"121","volume":"16","author":"IT Mak","year":"2011","unstructured":"Mak IT, Chmielinska JJ, Kramer JH, Spurney CF, Weglicki WB (2011) Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: protection by substance P receptor blockade. Exp Clin Cardiol 16:121\u2013124","journal-title":"Exp Clin Cardiol"},{"issue":"5","key":"3677_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1634\/theoncologist.10-5-345","volume":"10","author":"R P\u00e9rez-Soler","year":"2005","unstructured":"P\u00e9rez-Soler R, Delord JP, Halpern A, Kelly K, Krueger J, Sureda BM, von Pawel J, Temel J, Siena S, Souli\u00e8res D, Saltz L, Leyden J (2005) HER1\/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1\/EGFR inhibitor rash management forum. Oncologist 10(5):345\u2013356","journal-title":"Oncologist"},{"key":"3677_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0192623308315827","volume":"36","author":"AP Brown","year":"2008","unstructured":"Brown AP, Dunstan RW, Courtney CL, Criswell KA, Graziano MJ (2008) Cutaneous lesions in the rat following administration of an irreversible inhibitor of erbB receptors, including the epidermal growth factor receptor. Toxicol Pathol 36:410\u2013419","journal-title":"Toxicol Pathol"},{"key":"3677_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"C Sawyers","year":"2004","unstructured":"Sawyers C (2004) Targeted cancer therapy. Nature 432:294\u2013297","journal-title":"Nature"},{"key":"3677_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc1913","volume":"6","author":"K Imai","year":"2006","unstructured":"Imai K, Takaoka A (2006) Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer 6:714\u2013727","journal-title":"Nat Rev Cancer"},{"key":"3677_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2018.00009","volume":"5","author":"J Dong","year":"2018","unstructured":"Dong J, Chen L (2018) Cardiotoxicity of anticancer therapeutics. Front Cardiovasc Med 5:1\u20138","journal-title":"Front Cardiovasc Med"},{"key":"3677_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3892\/mco.2016.800","volume":"4","author":"Z Chen","year":"2016","unstructured":"Chen Z, Ai D (2016) Cardiotoxicity associated with targeted cancer therapies. Mol Clin Oncol 4:675\u2013681","journal-title":"Mol Clin Oncol"},{"key":"3677_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00281-018-0675-z","volume":"40","author":"JE Choi","year":"2018","unstructured":"Choi JE, Di Nardo AD (2018) Skin neurogenic inflammation. Semin Immunopathol 40:249\u2013259","journal-title":"Semin Immunopathol"},{"key":"3677_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10741-006-9191-7","volume":"11","author":"MI Tejero-Taldo","year":"2006","unstructured":"Tejero-Taldo MI, Kramer JH, Mak I-T, Komarov AM, Chmielinska JJ, Weglicki WB (2006) The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Heart Fail Rev 11:35\u201344","journal-title":"Heart Fail Rev"},{"key":"3677_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10637-009-9218-8","volume":"28","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M (2010) The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Invest New Drugs 28:187\u2013193","journal-title":"Invest New Drugs"},{"key":"3677_CR30","first-page":"4790810","volume":"2017","author":"A He","year":"2017","unstructured":"He A, Alhariri JM, Sweren RJ, Kwatra MM, Kwatra SG (2017) Aprepitant for the treatment of chronic refractory pruritus. Biomed Res Int 2017:4790810","journal-title":"Biomed Res Int"},{"key":"3677_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13555-019-0305-2","volume":"9","author":"M Pojawa-Go\u0142ab","year":"2019","unstructured":"Pojawa-Go\u0142ab M, Jaworecka K, Reich A (2019) NK-1 receptor antagonists and pruritus: review of current literature. Dermatol Ther (Heidelb) 9:391\u2013405","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03677-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T20:14:41Z","timestamp":1608149681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03677-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["3677"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03677-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest; the sponsors had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, and in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}